Bio-Rad Ventures

Bio-Rad Ventures is the venture wing of Bio-Rad Laboratories, the Hercules, California life sciences and diagnostics company. The fund invests in early-stage startups developing life science research tools and specialized diagnostics, aligning with Bio-Rad’s core franchises in droplet digital PCR, chromatography, electrophoresis, flow cytometry, and clinical diagnostics. Founders building novel reagents, single-cell technologies, NGS adjacencies, autoimmune or transfusion diagnostics, or quality control workflows have thesis fit. The parent’s presence across both research and clinical lab markets gives the venture arm a wide aperture for tools that touch either segment.

The fund invests at Seed and Series A with checks of $1M to $5M. It is based in the United States and focuses on life sciences tools and diagnostics. There is no stated AI focus.

Founders should be ready to discuss product fit relative to Bio-Rad’s existing instrument and reagent platforms, customer demand signals from pharma or clinical labs, and a regulatory strategy for diagnostics candidates. Limited public information is available about specific portfolio companies and named investing partners. The most credible path in is typically through scientific or commercial relationships at Bio-Rad’s business units, or via referrals from KOLs in droplet digital PCR, electrophoresis, or transfusion medicine.